Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 3/20 | 0.98 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.98 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.98 |
| ▸ | ADRA1A | P35348 | 3/20 | 0.98 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.98 |
| ▸ | DRD3 | P35462 | 3/20 | 0.98 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.98 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.98 |
| ▸ | DRD1 | P21728 | 2/20 | 0.98 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.98 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.63 |
| ▸ | DRD2 | P14416 | 7/20 | 0.60 |
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.54 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.54 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.54 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.54 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pipamperone SCHEMBL6621425 | 0.99 | HTR1A (1.00) | HTR1AADRA2ASLC6A4ADRA1AOPRM1 | |
| Pipamperone SCHEMBL2412 | 0.99 | HTR1A (1.00) | HTR1AADRA2ASLC6A4ADRA1AOPRM1 | |
| Pipamperone SCHEMBL364623 | 0.98 | HTR1A (0.98) | HTR1AADRA2ASLC6A4ADRA1AOPRM1 | |
| Pipamperone SCHEMBL14696833 | 0.98 | HTR1A (0.98) | HTR1AADRA2ASLC6A4ADRA1AOPRM1 | |
| Pipamperone SCHEMBL10533161 | 0.98 | HTR1A (0.98) | HTR1AADRA2ASLC6A4ADRA1AOPRM1 | |
| Pipamperone SCHEMBL4671026 | 0.98 | HTR1A (0.98) | HTR1AADRA2ASLC6A4ADRA1AOPRM1 | |
| Pipamperone SCHEMBL8764867 | 0.98 | HTR1A (0.98) | HTR1AADRA2ASLC6A4ADRA1AOPRM1 | |
| Pipamperone SCHEMBL8327319 | 0.97 | HTR1A (0.96) | HTR1AADRA2ASLC6A4ADRA1AOPRM1 | |
| Pipamperone SCHEMBL2552074 | 0.97 | HTR1A (0.96) | HTR1AADRA2ASLC6A4ADRA1AOPRM1 | |
| Pipamperone SCHEMBL21357035 | 0.96 | HTR1A (0.94) | HTR1AADRA2ASLC6A4ADRA1AOPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 329 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122010895-A | Preparation method of N-hydroxyethyl-3, 4-methylenedioxy aniline | 浙江鼎龙科技股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-119836121-A | Perovskite solar cell based on piperonyl amine additive and preparation method thereof | 华北电力大学 | 2025-04-15 | — | — | CN | claimed |
| CN-118530208-A | Piper-amid compounds and application thereof | 扬州大学 | 2024-08-23 | — | — | CN | claimed |
| CN-118440109-A | Method for synthesizing low-threshold perovskite laser material by taking piperonyl amine as ligand | 天津大学 | 2024-08-06 | — | — | CN | claimed |
| CN-118203664-A | Composition containing at least one natural or synthetic N-alkylamide as active substance and method for producing same | 埃利奥诺公司 | 2024-06-18 | — | — | CN | claimed |
| CN-118126017-A | Preparation method of 3, 4-methylenedioxy-phenylglycolic acid | 山东新和成药业有限公司 | 2024-06-04 | — | — | CN | claimed |
| CN-117982471-A | Application of orange yellow piperamide in preparation of medicine for treating acute kidney injury | 安徽医科大学 | 2024-05-07 | — | — | CN | claimed |
| CN-115925672-B | Preparation method of oxolinic acid intermediate | 湖北龙翔药业科技股份有限公司 | 2024-03-22 | — | — | CN | claimed |
| CN-114316951-B | Cadmium-based two-dimensional hybridization perovskite long afterglow material, and preparation method and application thereof | 南京邮电大学 | 2023-12-22 | — | — | CN | claimed |
| CN-111868072-B | Peptoid compound, preparation method thereof, nano carrier and pharmaceutical composition | 京东方科技集团股份有限公司 | 2023-08-29 | — | — | CN | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| JP-2000509406-A | — | — | 2000-07-25 | — | — | JP | claimed |
| EP-0956031-A1 | INHIBITION OF 26S AND 20S PROTEASOME BY INDANONES | CV THERAPEUTICS, INC. (US) | 1999-11-17 | — | — | EP | claimed |
| CN-1231612-A | Inhibition of 2,3-dihydrogen-indone to 26S and 20S prolease | CV THERAPEUTICS INC (US) | 1999-10-13 | — | — | CN | claimed |
| CN-1180073-A | Synthetic process of medicinal intermediate piperonyl amine | FEED INST OF CHINESE ACADEMY O (CN) | 1998-04-29 | — | — | CN | claimed |
| WO-1998013061-A1 | INHIBITION OF 26S AND 20S PROTEASOME BY INDANONES | CV THERAPEUTICS, INC. (US) | 1998-04-02 | — | — | WO | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |